Cargando…
Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897157/ https://www.ncbi.nlm.nih.gov/pubmed/35131649 http://dx.doi.org/10.1016/j.esmoop.2022.100381 |
| _version_ | 1784663342237876224 |
|---|---|
| author | Del Re, M. Omarini, C. Diodati, L. Palleschi, M. Meattini, I. Crucitta, S. Lorenzini, G. Isca, C. Fontana, A. Livi, L. Piacentini, F. Fogli, S. De Giorgi, U. Danesi, R. |
| author_facet | Del Re, M. Omarini, C. Diodati, L. Palleschi, M. Meattini, I. Crucitta, S. Lorenzini, G. Isca, C. Fontana, A. Livi, L. Piacentini, F. Fogli, S. De Giorgi, U. Danesi, R. |
| author_sort | Del Re, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8897157 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88971572022-03-06 Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients Del Re, M. Omarini, C. Diodati, L. Palleschi, M. Meattini, I. Crucitta, S. Lorenzini, G. Isca, C. Fontana, A. Livi, L. Piacentini, F. Fogli, S. De Giorgi, U. Danesi, R. ESMO Open Correspondence Elsevier 2022-02-04 /pmc/articles/PMC8897157/ /pubmed/35131649 http://dx.doi.org/10.1016/j.esmoop.2022.100381 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Correspondence Del Re, M. Omarini, C. Diodati, L. Palleschi, M. Meattini, I. Crucitta, S. Lorenzini, G. Isca, C. Fontana, A. Livi, L. Piacentini, F. Fogli, S. De Giorgi, U. Danesi, R. Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients |
| title | Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients |
| title_full | Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients |
| title_fullStr | Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients |
| title_full_unstemmed | Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients |
| title_short | Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients |
| title_sort | reply to comments on: drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897157/ https://www.ncbi.nlm.nih.gov/pubmed/35131649 http://dx.doi.org/10.1016/j.esmoop.2022.100381 |
| work_keys_str_mv | AT delrem replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients AT omarinic replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients AT diodatil replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients AT palleschim replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients AT meattinii replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients AT crucittas replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients AT lorenzinig replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients AT iscac replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients AT fontanaa replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients AT livil replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients AT piacentinif replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients AT foglis replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients AT degiorgiu replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients AT danesir replytocommentsondrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatients |